Salesforce [CRM]
As of 2026-07-29 · spot $188.46 · This memo issues no position verdict. What follows establishes what is investable and at what size. Whether to own it is the book's decision.
This is the first cluster tonight in which an options vehicle is actually available, and that is unusual enough to be a finding in its own right rather than a box ticked.
Tonight's record across names where the chain was actually pulled:
| Name | Chain depth found | Verdict |
|---|---|---|
| HCA | 18 contracts maximum open interest across an entire March-2027 expiry | Uninvestable |
| GMED | 13 | Uninvestable |
| CRDO | 78 | Uninvestable |
| ISSC | 506 | Uninvestable |
| KNSA | 2,598 total across the chain | Marginal |
| CRM | 4,229 at a single strike, 48 contracts in the scanned window | Investable |
| ADBE | 3,356 at a single strike | Investable |
| WDAY | 6,771 at a single strike | Investable |
| PANW | 2,713 at a single strike | Investable |
| CRWD | 5,883 at a single strike | Investable |
Nine of ten names checked tonight before this cluster had chains that could not be filled at any size. All five names here can be. The Liquidity Criteria exists because "a vehicle that cannot be filled is not a vehicle" — and the correct response to passing it is to quantify the pass, not to assert it.
| Metric | Value | Basis |
|---|---|---|
| 3-month average daily volume | 14,757,170 shares | 62 sessions to 2026-07-28, split-adjusted |
| 3-month average daily value | $2,781m | VWAP-weighted |
| 252-day volatility | 40.6% | screen record, consistent with option IV of ~49% |
Sizing implication. At 20% of ADV as a one-day participation ceiling, a full position can be built or exited in a single session up to ~$556m. Liquidity does not constrain any plausible size for this book. The constraint on CRM is the −0.9pp implied-path margin, not the ability to trade it.
Liquidity Criteria: PASS.
Scanned: calls, expiry 2026-11-01 to 2027-02-28, strikes $160–$236 (0.85× to 1.25× spot). 48 contracts returned.
Snapshots are live quotes and Greeks from the Alpaca options entitlement, top-level symbols= path.
| Contract | Expiry | Strike | Open interest | Bid | Ask | Spread | Bid size | Ask size | IV | Delta |
|---|---|---|---|---|---|---|---|---|---|---|
| CRM270115C00200000 | 2027-01-15 | 200 | 4,229 | 19.97 | 20.88 | 4.4% | 456 | 346 | 49.6% | 0.498 |
| CRM270115C00230000 | 2027-01-15 | 230 | 3,845 | — | — | — | — | — | — | — |
| CRM270115C00220000 | 2027-01-15 | 220 | 3,679 | 13.31 | 14.16 | 6.2% | 24 | 144 | 48.5% | 0.382 |
| CRM261218C00200000 | 2026-12-18 | 200 | 3,629 | — | — | — | — | — | — | — |
| CRM261120C00180000 | 2026-11-20 | 180 | 3,024 | 24.56 | 26.64 | 8.1% | 179 | 221 | 53.9% | 0.612 |
| CRM270115C00190000 | 2027-01-15 | 190 | 2,573 | 23.61 | 25.16 | 6.4% | 404 | 165 | 49.7% | 0.559 |
| CRM270115C00210000 | 2027-01-15 | 210 | — | 15.91 | 17.22 | 7.9% | 236 | 50 | 48.5% | 0.437 |
The Jan-2027 $200 call is the reference contract: 4,229 open interest, a 4.4% bid/ask, and 456×346 contracts of quoted size. At $20.88 per contract that is roughly $722k of immediately quoted offer — an order of magnitude beyond anything HCA, GMED or CRDO could absorb, and fillable without working the order.
Structures that are actually fillable on this chain: - Outright Jan-27 $200 call — 4,229 OI, 4.4% spread, delta 0.498. The cleanest expression. - Jan-27 $190/$220 call spread — both legs quoted (23.61/25.16 and 13.31/14.16), OI 2,573 and 3,679. Net debit ~$11.85 mid. Defined risk. Note the $220 leg's bid size is only 24 contracts, so the spread must be legged or worked; it is fillable but not at unlimited size. - Nov-20-2026 $180 call — 3,024 OI, delta 0.612, but IV 53.9% versus 48.5% for Jan-2027. The November expiry is pricing the Q2 FY27 print; the January expiry is not. A 5.4-vol-point term-structure premium sits precisely on the catalyst.
Structure I am not proposing, and why: anything at strikes above $236 or below $160 was outside the scanned window, so I make no claim about its depth. Stating that boundary is part of the pull, not a gap in it.
Presented as parameters, not as a recommendation.
Vehicle choice. The implied-path margin is −0.9pp, i.e. inside the noise. A structure whose payoff depends on multiple re-rating rather than on operating outperformance is the coherent expression, because §3 of the Valuation file shows the entire disagreement sits in the exit multiple. The Jan-2027 call at delta ~0.50 gives that exposure with a defined maximum loss, which is the appropriate vehicle for a thesis the analysis explicitly cannot resolve.
Entry. No entry trigger is defended here. Momentum is weak (P/S at the 5th percentile, price −14.5% over five years) and the Momentum Criteria is MEASURED — it governs when, never whether. A book that wants confirmation should wait for the Q3 FY27 print (~early Dec 2026), which is the first period in which management has committed to organic acceleration. That is also, not coincidentally, after the Jan-2027 option's vega has been paid for.
Sizing. Inverse-volatility. CRM's 40.6% realised volatility is the lowest of the five names in this cluster, so it carries the largest weight of the five on that rule. That is the interim control the Downside Criteria relies on and it operates without a judgement input.
Invalidation. Two hard, dated, falsifiable levels: 1. Q2 FY27 organic growth (reported less the disclosed Informatica contribution) below 6% — the bottom of the company's own implied guide. That breaks the deceleration-is-cyclical premise. 2. cRPO growth below 10% in any quarter. cRPO is the only leading indicator Salesforce publishes and the only thing standing in for the retention rate it declines to disclose.
What does not constitute invalidation: a fall in GAAP EPS. As Research §6a establishes, $558m of the $2,107m Q1 net income was a strategic-investment mark. The EPS line will fall when that reverses and it will mean nothing about the business.